Allowing researchers to share and explore curated genomic analyses of AD.
The analyses accessible through Agora represent the culmination of over five years of research from the dozens of scientists that are part of the NIH-led Accelerating Medicines Partnership – Alzheimer’s Disease (AMP-AD) Target Discovery and Preclinical Validation Project.
The analyses accessible through Agora represent the culmination of over five years of research from the dozens of scientists that are part of the NIH-led Accelerating Medicines Partnership – Alzheimer’s Disease (AMP-AD) Target Discovery and Preclinical Validation Project.
